RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+25.77%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$4.05B
AUM Growth
+$4.05B
(+8.5%)
Cap. Flow
-$190M
Cap. Flow
% of AUM
-4.69%
Top 10 Holdings %
Top 10 Hldgs %
37.5%
Holding
124
New
3
Increased
35
Reduced
29
Closed
20
Top Buys
| 1 |
Eli Lilly
LLY
|
$40.5M |
| 2 |
Celldex Therapeutics
CLDX
|
$18.6M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
$18.1M |
| 4 |
Immunovant
IMVT
|
$14.3M |
| 5 |
Ultragenyx Pharmaceutical
RARE
|
$13.3M |
Top Sells
Sector Composition
| 1 | Healthcare | 97.34% |
| 2 | Consumer Staples | 1.42% |
| 3 | Industrials | 1.03% |
